Form 8-K - Current report:
SEC Accession No. 0001437749-17-001514
Filing Date
2017-02-02
Accepted
2017-02-02 11:25:48
Documents
3
Period of Report
2017-02-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20170202_8k.htm 8-K 16804
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 20482
3 img.jpg GRAPHIC 8813
  Complete submission text file 0001437749-17-001514.txt   50947
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 17567299
SIC: 2836 Biological Products, (No Diagnostic Substances)